Evidence check: ACTN3 in the context of Darmgesundheit

ACTN3 is primarily a muscle-related gene, encoding α-actinin-3 in fast-twitch fibers, and is well-studied for sprint/power performance. In the context of gut health, there is no direct, robust human evidence linking ACTN3 variants (e.g., R577X) to intestinal barrier function, microbiome composition, or inflammatory bowel disease. Any proposed connection via systemic inflammation or the muscle-gut axis remains speculative and lacks clinical validation. If MyBody-X markets ACTN3 for gut health, this is likely a marketing claim without scientific backing. The evidence grade is 'mechanistic/unclear' at best. Consumers should not base dietary or gut health decisions on this single gene. For genuine gut health concerns, established clinical tests (e.g., calprotectin, zonulin, microbiome analysis) and medical consultation are recommended.